Agilent Technologies, Inc. (NYSE:A) CEO Sells $1,546,018.37 in Stock

Agilent Technologies, Inc. (NYSE:A) CEO Michael R. Mcmullen sold 22,481 shares of the company’s stock in a transaction on Friday, November 17th. The stock was sold at an average price of $68.77, for a total value of $1,546,018.37. Following the completion of the sale, the chief executive officer now owns 336,637 shares of the company’s stock, valued at $23,150,526.49. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Agilent Technologies, Inc. (NYSE:A) traded up $0.06 during trading on Wednesday, reaching $65.89. The company’s stock had a trading volume of 1,690,108 shares, compared to its average volume of 1,864,243. The company has a debt-to-equity ratio of 0.37, a quick ratio of 2.85 and a current ratio of 3.30. Agilent Technologies, Inc. has a 52 week low of $44.11 and a 52 week high of $70.93. The stock has a market capitalization of $21,317.89, a PE ratio of 27.95, a PEG ratio of 2.00 and a beta of 1.27.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Monday, November 20th. The medical research company reported $0.67 earnings per share for the quarter, beating analysts’ consensus estimates of $0.62 by $0.05. The business had revenue of $1.19 billion for the quarter, compared to analyst estimates of $1.17 billion. Agilent Technologies had a return on equity of 16.96% and a net margin of 15.30%. The company’s revenue was up 7.0% on a year-over-year basis. During the same period in the prior year, the company earned $0.59 earnings per share. equities research analysts predict that Agilent Technologies, Inc. will post 2.58 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 24th. Stockholders of record on Tuesday, January 2nd will be issued a $0.149 dividend. The ex-dividend date of this dividend is Friday, December 29th. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.13. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.90%. Agilent Technologies’s dividend payout ratio is currently 25.24%.

Hedge funds have recently made changes to their positions in the company. BlackRock Inc. lifted its position in shares of Agilent Technologies by 1.2% in the second quarter. BlackRock Inc. now owns 23,392,338 shares of the medical research company’s stock valued at $1,387,400,000 after acquiring an additional 273,119 shares in the last quarter. Vanguard Group Inc. lifted its position in Agilent Technologies by 3.0% during the second quarter. Vanguard Group Inc. now owns 22,093,669 shares of the medical research company’s stock worth $1,310,374,000 after buying an additional 637,698 shares in the last quarter. JPMorgan Chase & Co. lifted its position in Agilent Technologies by 45.2% during the second quarter. JPMorgan Chase & Co. now owns 12,145,610 shares of the medical research company’s stock worth $720,358,000 after buying an additional 3,779,099 shares in the last quarter. Bank of New York Mellon Corp lifted its position in Agilent Technologies by 1.5% during the second quarter. Bank of New York Mellon Corp now owns 5,721,557 shares of the medical research company’s stock worth $339,346,000 after buying an additional 84,801 shares in the last quarter. Finally, American Century Companies Inc. lifted its position in Agilent Technologies by 5.5% during the second quarter. American Century Companies Inc. now owns 4,582,086 shares of the medical research company’s stock worth $271,764,000 after buying an additional 238,522 shares in the last quarter.

A number of equities research analysts recently weighed in on the company. Deutsche Bank set a $68.00 price objective on Agilent Technologies and gave the stock a “buy” rating in a research note on Wednesday, August 16th. Morgan Stanley restated an “overweight” rating on shares of Agilent Technologies in a research note on Tuesday, November 14th. Bank of America upped their price objective on Agilent Technologies from $66.00 to $68.00 and gave the stock an “equal weight” rating in a research note on Wednesday, August 16th. J P Morgan Chase & Co reiterated an “overweight” rating and issued a $70.00 price target on shares of Agilent Technologies in a research note on Wednesday, August 16th. Finally, Goldman Sachs Group reiterated a “neutral” rating and issued a $68.00 price target on shares of Agilent Technologies in a research note on Tuesday, September 26th. Six analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. The stock has an average rating of “Buy” and a consensus price target of $68.34.

TRADEMARK VIOLATION NOTICE: “Agilent Technologies, Inc. (NYSE:A) CEO Sells $1,546,018.37 in Stock” was first published by StockNewsTimes and is the property of of StockNewsTimes. If you are viewing this piece of content on another website, it was illegally stolen and reposted in violation of international copyright & trademark laws. The legal version of this piece of content can be accessed at https://stocknewstimes.com/2017/12/06/agilent-technologies-inc-a-ceo-michael-r-mcmullen-sells-22481-shares.html.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Insider Buying and Selling by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply